Wellington Shields Capital Management LLC Sells 703 Shares of GE HealthCare Technologies Inc. $GEHC

Wellington Shields Capital Management LLC lowered its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 22.6% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 2,403 shares of the company’s stock after selling 703 shares during the quarter. Wellington Shields Capital Management LLC’s holdings in GE HealthCare Technologies were worth $178,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently bought and sold shares of the stock. Lineweaver Wealth Advisors LLC bought a new stake in GE HealthCare Technologies during the second quarter worth $592,000. Exome Asset Management LLC bought a new stake in GE HealthCare Technologies in the first quarter valued at approximately $2,050,000. Bridge Creek Capital Management LLC raised its stake in GE HealthCare Technologies by 58.2% in the second quarter. Bridge Creek Capital Management LLC now owns 31,852 shares of the company’s stock valued at $2,359,000 after buying an additional 11,719 shares during the period. Czech National Bank raised its stake in GE HealthCare Technologies by 6.6% in the second quarter. Czech National Bank now owns 111,923 shares of the company’s stock valued at $8,290,000 after buying an additional 6,889 shares during the period. Finally, Swedbank AB raised its stake in GE HealthCare Technologies by 71.9% in the second quarter. Swedbank AB now owns 128,101 shares of the company’s stock valued at $9,488,000 after buying an additional 53,575 shares during the period. Institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Trading Down 0.6%

GEHC stock opened at $74.47 on Tuesday. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.95 and a current ratio of 1.18. The company’s 50-day simple moving average is $75.09 and its 200 day simple moving average is $73.22. GE HealthCare Technologies Inc. has a 52 week low of $57.65 and a 52 week high of $94.80. The company has a market capitalization of $33.92 billion, a PE ratio of 15.39, a price-to-earnings-growth ratio of 2.82 and a beta of 1.13.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings results on Wednesday, October 29th. The company reported $1.07 EPS for the quarter, beating the consensus estimate of $1.05 by $0.02. GE HealthCare Technologies had a net margin of 10.94% and a return on equity of 22.52%. The business had revenue of $5.14 billion for the quarter, compared to the consensus estimate of $5.07 billion. During the same period in the prior year, the company posted $1.14 earnings per share. GE HealthCare Technologies’s revenue was up 5.8% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. As a group, sell-side analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 14th. Investors of record on Friday, October 24th will be paid a $0.035 dividend. The ex-dividend date is Friday, October 24th. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio is 2.89%.

Analysts Set New Price Targets

GEHC has been the topic of several research analyst reports. Wall Street Zen lowered GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research note on Saturday, September 20th. Wells Fargo & Company dropped their price objective on shares of GE HealthCare Technologies from $89.00 to $87.00 and set an “overweight” rating on the stock in a research report on Thursday. Weiss Ratings reissued a “hold (c+)” rating on shares of GE HealthCare Technologies in a research report on Tuesday, October 14th. Barclays began coverage on shares of GE HealthCare Technologies in a research report on Monday, October 13th. They issued an “equal weight” rating and a $86.00 price objective on the stock. Finally, Evercore ISI increased their price objective on shares of GE HealthCare Technologies from $88.00 to $92.00 and gave the company an “outperform” rating in a research report on Thursday, October 30th. Six investment analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $86.10.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.